Cargando…
Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
BACKGROUND: Cameroon, in west central Africa, has an extraordinary degree of HIV diversity, presenting a major challenge for the development of an effective HIV vaccine. Given the continuing need to closely monitor the emergence of new HIV variants in the country, we analyzed HIV-1 genetic diversity...
Autores principales: | Tongo, Marcel, Martin, Darren P, Zembe, Lycias, Mpoudi-Ngole, Eitel, Williamson, Carolyn, Burgers, Wendy A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560183/ https://www.ncbi.nlm.nih.gov/pubmed/23339631 http://dx.doi.org/10.1186/1743-422X-10-29 |
Ejemplares similares
-
The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012) -
P16-44. Investigating T cell immune responses in Cameroon, a country with broad HIV-1 genetic diversity
por: Tongo, M, et al.
Publicado: (2009) -
Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country
por: Tongo, Marcel, et al.
Publicado: (2015) -
HIV and Hepatitis C Virus Coinfection, Cameroon
por: Laurent, Christian, et al.
Publicado: (2007) -
HIV-1 diversity in Cameroon: new insights on the evolution of the virus
por: Simon, T Aime Marcel, et al.
Publicado: (2012)